Latest revenue
$242.4M
as of 2026-03-31
Latest net income
$3.2M
as of 2026-03-31
Net margin
1.3%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $2.84B
- Enterprise value
- $2.84B
- P/E (trailing)
- 1730.5×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $31.00
- 52-wk low
- $14.96
- Beta
- —
- Shares out
- 113.2M
5-year trend
What this company does
Item 1. Business Our Company Warby Parker is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. We stand for fun, creativity, and doing good in the world. Every day, our team of over 4,000 employees is focused on our mission to inspire and impact the world with vision, purpose, and style (without charging a premium for it). Our ultimate objective is to provide vision for all. As a pioneer of the direct-to-consumer model, we design our glasses in-house at our New York City headquarters and sell directly to customers, enabling us to make high-quality, designer eyewear more accessible, with simple, unified pricing…
AI summary unavailable — showing raw filing excerpt
Generated from WRBY's filing dated 2026-02-26
Key risks
Item 1A. Risk Factors Investing in our Class A common stock involves a high degree of risk and uncertainty. You should consider and read carefully all of the risks and uncertainties described below, together with all of the other information included in this Annual Report on Form 10-K, including our audited consolidated financial statements and related notes and “Management’s Discussion and Analysis of Financial Condition and Results of Operation”, before making an investment decision. The occurrence of any of the following risks and uncertainties could materially and adversely affect our business, financial condition, or results of operations. In such case, the trading price of our Class A…
AI summary unavailable — showing raw filing excerpt
Generated from WRBY's filing dated 2026-02-26
Profitability
Gross margin
54.0%
2.5%Operating margin
-0.6%
84.3%Net margin
0.2%
107.1%Return on equity
0.4%
107.4%Return on assets
0.2%
107.6%Leverage
Debt / equity
0.96×
2.9%Debt / assets
49.0%
1.5%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $242.4M | +8.3% | $3.2M | -8.5% | 1.3% |
Q4 2025 2025-12-31 | $212.0M | +11.2% | $-9.4M | -37.1% | -4.4% |
Q3 2025 2025-09-30 | $221.7M | +15.2% | $5.9M | +244.3% | 2.6% |
Q2 2025 2025-06-30 | $214.5M | +13.9% | $1.7M | +125.4% | 0.8% |
Q1 2025 2025-03-31 | $223.8M | +11.9% | $3.5M | +229.6% | 1.6% |
Q4 2024 2024-12-31 | $190.6M | — | $-6.9M | — | -3.6% |
Q3 2024 2024-09-30 | $192.4M | +13.3% | $-4.1M | +76.6% | -2.1% |
Q2 2024 2024-06-30 | $188.2M | +13.3% | $-6.8M | +57.5% | -3.6% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Ophthalmic Goods · SIC 3851
Your notes
Keep private notes on WRBY — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$43.4M
Net activity
−$43.4M
Distinct insiders
7
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns WRBY
Institutional value
$1.00B
Total shares held
48.7M
Distinct holders
157
-120 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | JPMORGAN CHASE & CO | 10.1M | $205.2M | +409.0K (+4.2%) | Added |
| 2 | BlackRock, Inc. | 7.3M | $152.9M | -721.6K (-9.0%) | Trimmed |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.3M | $112.3M | — | New |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.4M | $92.8M | — | New |
| 5 | VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. | 3.0M | $63.8M | +722.6K (+31.3%) | Added |
| 6 | DIMENSIONAL FUND ADVISORS LP | 1.7M | $36.3M | +166.2K (+10.7%) | Added |
| 7 | Bank of New York Mellon Corp | 1.5M | $32.1M | -1.1M (-41.3%) | Trimmed |
| 8 | Capital World Investors | 1.4M | $28.7M | — | New |
| 9 | Artisan Partners Limited Partnership | 1.3M | $28.3M | +243.6K (+22.2%) | Added |
| 10 | JENNISON ASSOCIATES LLC | 960.3K | $20.2M | -5.0K (-0.5%) | Trimmed |
| 11 | TimesSquare Capital Management, LLC | 928.7K | $19.6M | -424.9K (-31.4%) | Trimmed |
| 12 | Artemis Investment Management LLP | 926.0K | $19.5M | — | New |
| 13 | UBS Group AG | 771.7K | $16.3M | +35.3K (+4.8%) | Added |
| 14 | VANGUARD FIDUCIARY TRUST CO | 691.3K | $14.6M | — | New |
| 15 | BNP PARIBAS FINANCIAL MARKETS | 540.3K | $11.4M | +322.2K (+147.8%) | Added |
| 16 | NEW YORK STATE COMMON RETIREMENT FUND | 521.0K | $11.0M | +74.7K (+16.7%) | Added |
| 17 | WELLS FARGO & COMPANY/MN | 469.5K | $9.9M | +133.6K (+39.8%) | Added |
| 18 | KING LUTHER CAPITAL MANAGEMENT CORP | 456.1K | $9.6M | +32.8K (+7.8%) | Added |
| 19 | Nuveen, LLC | 452.2K | $9.5M | -72.4K (-13.8%) | Trimmed |
| 20 | CITIGROUP INC | 450.3K | $9.5M | +225.8K (+100.5%) | Added |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once WRBY's latest filing finishes processing.